tiprankstipranks
Immunome, Inc. (IMNM)
NASDAQ:IMNM
US Market
IMNM
Immunome
RESEARCH TOOLSreports
Want to see IMNM full AI Analyst Report?

Immunome (IMNM) Stock News & Sentiment

449 Followers
Immunome Price Target Maintained at $35 as Analyst Sees Best-in-Class Potential for Varegacestat in Desmoid Tumors
Premium
Ratings
Immunome Price Target Maintained at $35 as Analyst Sees Best-in-Class Potential for Varegacestat in Desmoid Tumors
7d ago
IMNM
Analyst Reiterates Buy on Immunome, Maintains $40 Price Target on Varegacestat Progress and Pipeline Upside
Premium
Ratings
Analyst Reiterates Buy on Immunome, Maintains $40 Price Target on Varegacestat Progress and Pipeline Upside
8d ago
IMNM
Immunome: Best-in-Class Varegacestat Data and Deep ADC Pipeline Support Buy Rating and Favorable Risk‑Reward
Premium
Ratings
Immunome: Best-in-Class Varegacestat Data and Deep ADC Pipeline Support Buy Rating and Favorable Risk‑Reward
2M ago
IMNM
Immunome: Buy Rating on Best-in-Class Varegacestat Opportunity and Differentiated Next-Generation ADC Oncology Platform
Premium
Ratings
Immunome: Buy Rating on Best-in-Class Varegacestat Opportunity and Differentiated Next-Generation ADC Oncology Platform
3M ago
IMNM
Immunome: Advancing Best-in-Class Varegacestat and a Data-Driven ADC Pipeline Support Buy Rating and $40 Target
Premium
Ratings
Immunome: Advancing Best-in-Class Varegacestat and a Data-Driven ADC Pipeline Support Buy Rating and $40 Target
3M ago
IMNM
Immunome: Differentiated Oncology Portfolio and ADC Platform Underpin Buy Rating and $40 Price Target
Premium
Ratings
Immunome: Differentiated Oncology Portfolio and ADC Platform Underpin Buy Rating and $40 Price Target
3M ago
IMNM
Immunome Announces Follow-On Public Offering Pricing
Premium
Company Announcements
Immunome Announces Follow-On Public Offering Pricing
5M ago
8K
IMNM
More IMNM News >

IMNM News on the Web

LifeSci Capital Keeps Their Buy Rating on Immunome (IMNM)
TipRanks News
Bullish
Immunome price target lowered to $33 from $37 at Leerink
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Aveanna Healthcare Holdings (AVAH) and QT Imaging Holdings (QTI)
TipRanks News
Bullish
Immunome Price Target Maintained at $35 as Analyst Sees Best-in-Class Potential for Varegacestat in Desmoid Tumors
TipRanks News
Bullish
Wedbush Remains a Buy on Immunome (IMNM)
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), Coherus Biosciences (CHRS)
TipRanks News
Neutral
Analysts Conflicted on These Healthcare Names: Kyverna Therapeutics, Inc. (KYTX), Immunome (IMNM) and Prime Medicine, Inc. (PRME)
TipRanks News
Bullish
Piper Sandler Remains a Buy on Immunome (IMNM)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
IMNM
Sector Average
Media Buzz
This Week4 articles
Weekly Average4.5 articles
News Sentiment
This Week100%
Sector Average76%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMNM’s Media Buzz Sentiment?
4 articles about IMNM were published this week. In an average week, 4.5 articles are published.
    What is IMNM’s weekly average amount of articles?
    In an average week, 4.5 articles about IMNM are published.
      What is IMNM’s News Sentiment?
      100% of articles about IMNM were positive this week, compared to its sector average of 76%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        CGENCompugen
        PROKProKidney
        ROIVRoivant Sciences
        Showing the stocks with the most bullish news sentiment over the past week